MARATTO

article · Journal of the International AIDS Society

In‐utero exposure to tenofovir‐containing pre‐exposure prophylaxis and bone mineral content in HIV‐unexposed infants in South Africa

20242 citationsOpen accessStellenbosch University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

In a randomized controlled trial, there were no differences in BMC of the WBH and LS between infants exposed to in-utero TDF-FTC PrEP and unexposed infants in the first 18 months of life.

Research topics

  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/jia2.26379

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.